


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T14:02:16Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12407753" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12407753</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-id journal-id-type="pmc-domain-id">3848</journal-id><journal-id journal-id-type="pmc-domain">biorxiv</journal-id><journal-id journal-id-type="publisher-id">BIORXIV</journal-id><journal-title-group><journal-title>bioRxiv</journal-title></journal-title-group><issn pub-type="epub">2692-8205</issn><publisher><publisher-name>Cold Spring Harbor Laboratory Preprints</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12407753</article-id><article-id pub-id-type="pmcid-ver">PMC12407753.1</article-id><article-id pub-id-type="pmcaid">12407753</article-id><article-id pub-id-type="pmcaiid">12407753</article-id><article-id pub-id-type="pmid">40909626</article-id><article-id pub-id-type="doi">10.1101/2025.08.25.670309</article-id><article-version-alternatives><article-version article-version-type="pmc-version">1</article-version><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>
CCAAT-enhancer binding protein delta functions as a tumor suppressor gene in acute myeloid leukemia
</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Prajapati</surname><given-names initials="SC">Subhash C.</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Meydan</surname><given-names initials="C">Cem</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Neelamraju</surname><given-names initials="Y">Yaseswini</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wang</surname><given-names initials="Z">Zhenjia</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Fan</surname><given-names initials="H">Hao</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dunham</surname><given-names initials="N">Nicholas</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dillon</surname><given-names initials="R">Richard</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gandara</surname><given-names initials="JA">Jorge A</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lee</surname><given-names initials="T">Tak</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sheridan</surname><given-names initials="C">Caroline</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zumbo</surname><given-names initials="P">Paul</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Becker</surname><given-names initials="MW">Michael W.</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bullinger</surname><given-names initials="L">Lars</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Carroll</surname><given-names initials="MP">Martin P</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>D&#8217;Andrea</surname><given-names initials="RJ">Richard J</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Levine</surname><given-names initials="RL">Ross L</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mason</surname><given-names initials="C">Christopher</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-1850-1642</contrib-id></contrib><contrib contrib-type="author"><name name-style="western"><surname>Melnick</surname><given-names initials="AM">Ari M</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zang</surname><given-names initials="C">Chongzhi</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bekiranov</surname><given-names initials="S">Stefan</given-names></name></contrib><contrib contrib-type="author"><name name-style="western"><surname>Garrett-Bakelman</surname><given-names initials="FE">Francine E.</given-names></name></contrib></contrib-group><pub-date pub-type="epub"><day>27</day><month>8</month><year>2025</year></pub-date><issue-id pub-id-type="pmc-issue-id">496186</issue-id><elocation-id>2025.08.25.670309</elocation-id><pub-history><event event-type="pmc-release"><date><day>03</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-05 09:25:55.133"><day>05</day><month>09</month><year>2025</year></date></event></pub-history><permissions><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License</ext-link>, which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="nihpp-2025.08.25.670309v1.pdf"/><self-uri xlink:href="http://biorxiv.org/lookup/doi/10.1101/2025.08.25.670309">http://biorxiv.org/lookup/doi/10.1101/2025.08.25.670309</self-uri><self-uri content-type="pdf">nihpp-2025.08.25.670309.pdf</self-uri><abstract><title>Abstract</title><p>There is a continued need for identification of novel disease drivers of acute myeloid leukemia as many patients experience relapse and have poor clinical outcomes. Analyses from our study and publicly available datasets predicted CEBPD as a novel tumor suppressor gene in acute myeloid leukemia. Consistent with the analyses, CEBPD knockdown experiments showed activation of MAPK signaling with concomitant increase in cell growth rate, while upregulation experiments suggested induction of myeloid differentiation marker CD14 expression in AML cell lines OCI-AML2 and OCI-AML5. Consistent with a previous report, our genomics analyses and azacytidine treatment experiments suggested a role for DNA methylation in downregulation of CEBPD expression during AML pathogenesis. Altogether, our results provide experimental evidence for a tumor suppressor function of CEBPD in AML.</p></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>